Tether, known for its USDT stablecoin, is investing $200 million in Blackrock Neurotech, a leading brain-computer interface (BCI) company and competitor to Elon Musk’s Neuralink. This investment was announced on April 29, marking a significant expansion of Tether’s interests beyond cryptocurrencies into cutting-edge neuroscience.
Blackrock Neurotech, established in 2008 in Salt Lake City, Utah, specializes in neuroscience, neural engineering, and neural prosthetics. This partnership is set to advance technologies aiding individuals with paralysis and neurological disorders. With this move, Tether not only diversifies its portfolio but also becomes a major stakeholder in the promising field of BCI technology.
The investment signals Tether’s commitment to pioneering technologies that can improve human lives, showcasing its strategic vision for leveraging its financial resources for high-impact, technological advancements.
